0.5mg Tirzepatide: Where It Fits in the Mounjaro Schedule

Step 1: Understanding why the dose numbers differ between medicines

The confusion around 0.5mg tirzepatide usually starts with semaglutide. Wegovy's maintenance pathway runs from 0.25mg up to 2.4mg (or 7.2mg with the newer high-dose pen), so small fractions like 0.5mg appear constantly in semaglutide content. Tirzepatide's numbers are simply larger (the starting dose alone is 2.5mg) because the two molecules are chemically different, with different potencies and different target receptors. Comparing 0.5mg semaglutide to 2.5mg tirzepatide by the number is like comparing millilitres of two entirely different medications: the figure tells you nothing useful without the molecule beside it.

Tirzepatide activates both GIP and GLP-1 receptors simultaneously, a dual mechanism that no semaglutide product shares. That distinction matters clinically, not just pharmacologically, it shapes the trial evidence, the side-effect profile, and the dose increments the prescriber works through. If you've been researching online and landed on 0.5mg tirzepatide and want to understand why that strength doesn't exist in any licensed product, it's worth reading about how Mounjaro works so the dose numbers make sense in context.

Step 2: The licensed Mounjaro dose schedule from 2.5mg upwards

Mounjaro is supplied in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, each in a pre-filled KwikPen delivering four weekly injections. Treatment begins at 2.5mg for the first four weeks. That dose isn't therapeutic in the sense of producing substantial weight loss, its job is to let your gastrointestinal system settle before the medicine is increased. After four weeks, the prescriber typically moves to 5mg, then upwards in roughly four-week steps as tolerated.

Not everyone reaches 15mg. Some people find a lower maintenance dose works well for them; others tolerate the full titration without difficulty. The titration process is guided by your prescriber throughout, there's no standard rung that suits everyone. The KwikPen format means the dose is pre-set inside each pen, so you cannot adjust the amount delivered yourself. That's a deliberate safety design, not a limitation. Clinical trial data across the SURMOUNT programme found that people on the highest tolerated doses saw the greatest average weight reductions, with SURMOUNT-1 (published in the New England Journal of Medicine) reporting around 20–21% average body-weight reduction at 15mg over 72 weeks, figures that inform NICE's recommendation of tirzepatide under TA1026. For those who want to understand what the mid-range of the schedule looks like, our page on 7.5mg tirzepatide covers what patients typically experience at that stage of titration.

Step 3: What this means for anyone considering tirzepatide

If a website or seller is offering 0.5mg tirzepatide, pause before doing anything else. There is no licensed product at that strength, not from Eli Lilly, not under any UK authorisation. The MHRA has documented large-scale seizures of counterfeit weight-loss pens carrying plausible-sounding labels; a dose that doesn't correspond to any licensed product is a meaningful warning sign. You can verify any UK online pharmacy on the GPhC register in under a minute, search the pharmacy's name or registration number and confirm the premises registration is current. Legitimate pharmacies don't offer medicines outside their licensed specifications.

Cost is another area worth thinking about clearly. Pricing for private tirzepatide treatment varies by dose and provider, and the range is wide enough to feel confusing. The context behind Mounjaro pricing covers what different price points typically include (and exclude), which helps explain why headline figures vary so much. For a prescription medicine, the clinical oversight wrapped around it matters at least as much as the cost per pen.

The 5mg dose is the first step up from the starter, and it's where many people begin to notice the medicine's effects more clearly. Understanding what each increment involves helps set realistic expectations from the outset. A practical checking habit worth building: before your next dose increase, write down how you've been feeling over the past week (appetite changes, any nausea, energy levels) so your prescriber has something concrete to work with at review. It takes less than a minute and makes the clinical conversation much more useful.

Step 4: How a prescriber decides which dose is right for you

A prescriber considering tirzepatide for weight management looks at your BMI, your weight-related health conditions, your current medicines, and your medical history as a whole. The licensed private threshold is a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds may apply for some ethnic backgrounds under UK guidance. Meeting the eligibility criteria doesn't automatically mean any specific dose, that's determined as treatment progresses.

At nume, a GPhC-registered Independent Prescriber personally reviews each consultation the same day it's submitted. A real clinician reads your answers (your health history, current medications, and goals) and makes a clinical judgement. The process includes photo-ID and live weight verification, and our prescribers follow the same titration framework as any regulated UK prescriber. You can read more about our clinical approach or explore weight-loss treatment options more broadly. If tirzepatide is right for you, the 2.5mg pen is where every patient begins, not 0.5mg, not any other starting point. That's the licensed schedule, and it exists for good reason.